MPEP § 2420 — The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules
Ninth Edition, Revision 01.2024 · last revised R-07.2022
[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). See MPEP §§ 2412- 2419 for applications filed on or after July 1, 2022.]
The sequence rules (37 CFR 1.821 -1.825) set forth the requirements pertaining to patent applications containing nucleotide sequence and/or amino acid sequence disclosures filed under WIPO ST.25. See also MPEP § 608.05 and § 2422.03.
See PCT Rule 5 and Rule 13ter, and MPEP § 1823.02 and § 2422, for the requirements under the PCT for international applications subject to WIPO ST.25 requirements and that disclose nucleic acid or amino acid sequences.
Cited authority
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 2412 The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format
- 2419 Publishing of Patent Grants and Patent Application Publications with a “Sequence Listing XML”
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications
- 37 CFR 1.825 Amendments to add or replace a “Sequence Listing” and CRF copy thereof
- 608.05 “Sequence Listing,” “Large Tables,” or “Computer Program Listing Appendix” Submitted in ASCII Plain Text or a “Sequence Listing XML” Submitted as XML File Text
- 2422.03 Sequence Listing Submission
- PCT Rule 5 The Description
- PCT Rule 13 ter Nucleotide and/or Amino Acid Sequence Listings
- 1823.02 Filing Nucleotide and/or Amino Acid Sequence Listings in International Applications
- 2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25